(E)-2-cyano-3-phenyl-N-(5-phenyl-1,3,4-oxadiazol-2-yl)prop-2-enamide

Modify Date: 2024-09-18 19:37:17

(E)-2-cyano-3-phenyl-N-(5-phenyl-1,3,4-oxadiazol-2-yl)prop-2-enamide Structure
(E)-2-cyano-3-phenyl-N-(5-phenyl-1,3,4-oxadiazol-2-yl)prop-2-enamide structure
Common Name (E)-2-cyano-3-phenyl-N-(5-phenyl-1,3,4-oxadiazol-2-yl)prop-2-enamide
CAS Number 160893-87-8 Molecular Weight 316.31300
Density 1.342g/cm3 Boiling Point N/A
Molecular Formula C18H12N4O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name (E)-2-cyano-3-phenyl-N-(5-phenyl-1,3,4-oxadiazol-2-yl)prop-2-enamide
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.342g/cm3
Molecular Formula C18H12N4O2
Molecular Weight 316.31300
Exact Mass 316.09600
PSA 95.30000
LogP 3.93178
Index of Refraction 1.677

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UC6316275
CHEMICAL NAME :
2-Propenamide, 2-cyano-3-phenyl-N-(5-phenyl-1,3,4-oxadiazol-2-yl)-
CAS REGISTRY NUMBER :
160893-87-8
LAST UPDATED :
199603
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C18-H12-N4-O2
MOLECULAR WEIGHT :
316.34

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PHARAT Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- Volume(issue)/page/year: 49,880,1994
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PHARAT Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- Volume(issue)/page/year: 49,880,1994

 Synonyms

2-Propenamide,2-cyano-3-phenyl-N-(5-phenyl-1,3,4-oxadiazol-2-yl)
2-Cyano-3-phenyl-N-(5-phenyl-1,3,4-oxadiazol-2-yl)acrylamide
2-Cyano-3-phenyl-N-(5-phenyl-1,3,4-oxadiazol-2-yl)-2-propenamide